(Q30444086)

English

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI) (English)

1 reference

Europe PubMed Central

13 August 2017

1 reference

based on heuristic

inferred from title

11

object named as

W Martin Kast

1 reference

Europe PubMed Central

13 August 2017

Shreemanta Parida

1 reference

ORCID Public Data File 2021

Katherine S Panageas

2

object named as

Katherine S Panageas

1 reference

Europe PubMed Central

13 August 2017

Holden T. Maecker

8

object named as

Holden T Maecker

1 reference

Europe PubMed Central

13 August 2017

author name string

Sylvia Janetzki

1

1 reference

Europe PubMed Central

13 August 2017

Leah Ben-Porat

3

1 reference

Europe PubMed Central

13 August 2017

Jean Boyer

4

1 reference

Europe PubMed Central

13 August 2017

Cedrik M Britten

5

1 reference

Europe PubMed Central

13 August 2017

Timothy M Clay

6

1 reference

Europe PubMed Central

13 August 2017

Michael Kalos

7

1 reference

Europe PubMed Central

13 August 2017

Pedro Romero

9

1 reference

Europe PubMed Central

13 August 2017

Jianda Yuan

10

1 reference

Europe PubMed Central

13 August 2017

Axel Hoos

12

1 reference

Europe PubMed Central

13 August 2017

Elispot Proficiency Panel of the CVC Immune Assay Working Group

13

1 reference

Europe PubMed Central

13 August 2017

publication date

25 August 2007

1 reference

Europe PubMed Central

13 August 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

13 August 2017

57

1 reference

Europe PubMed Central

13 August 2017

303-315

1 reference

Europe PubMed Central

13 August 2017

3

1 reference

Europe PubMed Central

13 August 2017

https://scigraph.springernature.com/pub.10.1007/s00262-007-0380-6

0 references

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

20 June 2018

Establishing acceptance criteria for cell-mediated-immunity assays using frozen peripheral blood mononuclear cells stored under optimal and suboptimal conditions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

20 June 2018

A clinical development paradigm for cancer vaccines and related biologics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

20 June 2018

Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

20 June 2018

Measurement of cytokine release at the single cell level using the ELISPOT assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

20 June 2018

Validation overview of bio-analytical methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

20 June 2018

Immunological monitoring of cancer vaccine therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

20 June 2018

Monitoring immune responses in cancer patients receiving tumor vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

20 June 2018

Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

20 June 2018

Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

20 June 2018

Immunologic monitoring of clinical trials in patients with cancer: technology versus common sense

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

20 June 2018

Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

20 June 2018

Evaluation of the modified ELISPOT assay for gamma interferon production in cancer patients receiving antitumor vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

20 June 2018

Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

26 November 2018

Enumerating antigen-specific T-cell responses in peripheral blood: a comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

26 November 2018

Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

26 November 2018

Surrogate markers of response to cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

26 November 2018

Use of overlapping peptide mixtures as antigens for cytokine flow cytometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

26 November 2018

Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150634

26 November 2018

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721781

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721781

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of Elispot assays: influence of method and operator on variability of results

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721781

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardization and validation issues of the ELISPOT assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721781

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced rates and magnitude of immune responses detected against an HIV vaccine: effect of using an optimized process for isolating PBMC

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721781

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721781

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00262-007-0380-6

1 reference

Europe PubMed Central

13 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30444086&oldid=2058817972"